Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and
Byeong Keon Son, president of Wuestec, is taking over the post of CEO. The expansion of duties, described by the company as a major corporate repositioning, puts Son in charge of Wuestec's strategic direction, product development, distribution, and financial performance. Son joined Wuestec as president in 2000. Before then, he was in charge of strategic development at Gemini Consulting in New York.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.